Zobrazeno 1 - 7
of 7
pro vyhledávání: '"MM Pankrashkina"'
Autor:
O.Yu. Vinogradova, N.M. Pofirieva, A.E. Kersilova, MM Pankrashkina, Dzhariyat Shikhbabaeva, Mikhail Fominykh, Tatiana Nikitina, Tatyana Ionova, Vasily Shuvaev, E.V. Efremova, A.-P.A. Poshivai
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 2, Pp 176-184 (2019)
Aim. To develop a Russian version of MPN10 form for patients with myeloproliferative neoplasms (MPN) compliant with international recommendations. Materials & Methods. The trial included 57 patients treated in 2019 at the Moscow Municipal Center for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb445e5eb41995ff3358869ea3dda8cb
https://doi.org/10.21320/2500-2139-2020-13-2-176-184
https://doi.org/10.21320/2500-2139-2020-13-2-176-184
Autor:
NN Sharkunov, SV Voloshin, MM Pankrashkina, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, Immunology, Samory Mashela str., Moscow, Russian Federation, SN Tsareva, EV Motyko, Irina Martynkevich, Fominykh, DI Shikhbabaeva, Irina Zotova, NV Novitskaya, M V Chernikov, VA Shuvaev, VYu Udal’eva, OYu Vinogradova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 4, Pp 288-294 (2018)
Aim. To evaluate the clinical experience of bosutinib use for treatment of chronic myeloid leukemia (CML) patients with intolerance and resistance to other tyrosine kinase inhibitors (TKI), as well as to compare the obtained results with the data of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60db666a29e8a657dd3c09c125d38fb
http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf
http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf
Autor:
AV Chechetkin, E.V. Efremova, SV Voloshin, VA Shuvaev, Fominykh, MM Pankrashkina, Irina Martynkevich, LB Polushkina, KYu Krutikova, NN Sharkunov, OYu Vinogradova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 471-478 (2017)
Background. Myelofibrosis (primary myelofibrosis, postessential trombocythemia myelofibrosis, post-polycythemia myelofibrosis) is the most complex and pressing problem among all Ph-negative myeloproliferative diseases. The present article summarizes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74cd472b8350fcaf98af9c56cdd8dbe9
http://bloodjournal.ru/wp-content/uploads/2017/10/6_1.pdf
http://bloodjournal.ru/wp-content/uploads/2017/10/6_1.pdf
Autor:
AV Shubina, OYu Vinogradova, E. I. Emelina, GE Gendlin, MA Panteleev, MM Pankrashkina, E A Nikitin, Vadim V. Ptushkin, S A Lugovskaya, EA Dmitrieva, EE Markova, EG Arshanskaya, VV Glazunova, T N Obukhova, NK Khuazheva, Pochtar' Me, Valentina Ivanova, NG Novitskaya, YuB Kochkareva, LA Mukha, IE Lazarev, E. V. Naumova, SA Chernysh
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 271-281 (2017)
Background & Aims. This paper presents the results of the observational study of ibrutinib in patients with chronic lymphocytic leukemia (CLL), conducted in SP Botkin Municipal Clinical Hospital. The main objective was the analysis of complications o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c195876623d9edb1dbb58aad28254f
https://doi.org/10.21320/2500-2139-2017-10-3-271-281
https://doi.org/10.21320/2500-2139-2017-10-3-271-281
Autor:
Vadim V. Ptushkin, N.E. Tkachenko, EG Arshanskaya, MM Pankrashkina, M V Chernikov, O.Yu. Vinogradova
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 70-76 (2018)
Objective: To analyze the long-term efficacy and safety of ATR in adult patients with primary resistant ITP in real-world clinical practice. Materials and methods.The article contains long-term results analysis of ATR application under real clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::401324dcf61db0f836e80e71cc74ed68
https://pubmed.ncbi.nlm.nih.gov/30701925
https://pubmed.ncbi.nlm.nih.gov/30701925
Autor:
Ignatova AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Demina IA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Ptushkin VV; City Clinical Hospital Named After S.P. Botkin, Moscow, Russia., Khaspekova SG; National Medical Research Center for Cardiology, Moscow, Russia., Shustova ON; National Medical Research Center for Cardiology, Moscow, Russia., Pankrashkina MM; City Clinical Hospital Named After S.P. Botkin, Moscow, Russia., Ryabykh AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia., Obydennyi SI; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Center for Theoretical Problems of Physicochemical Pharmacology, Moscow, Russia., Strelkova OS; Lomonosov Moscow State University, Moscow, Russia., Polokhov DM; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Seregina EA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Poletaev AV; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Ataullakhanov FI; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; Center for Theoretical Problems of Physicochemical Pharmacology, Moscow, Russia., Kireev II; Lomonosov Moscow State University, Moscow, Russia., Mazurov AV; National Medical Research Center for Cardiology, Moscow, Russia., Maschan AA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Novichkova GA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Panteleev MA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; Center for Theoretical Problems of Physicochemical Pharmacology, Moscow, Russia.; Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Oct; Vol. 187 (2), pp. e38-e42. Date of Electronic Publication: 2019 Aug 18.
Autor:
Ptushkin VV; The City Clinical Hospital named after S.P. Botkin Moscow Department of Health, Moscow, Russia.; National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Russian Federation Ministry of Health, Moscow, Russia.; Russian National Medical Research University named after N.I. Pirogov, Russian Federation Ministry of Health. Department of Hematology, Oncology and Radiation Therapy, Moscow, Russia., Vinogradova OY; The City Clinical Hospital named after S.P. Botkin Moscow Department of Health, Moscow, Russia.; National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Russian Federation Ministry of Health, Moscow, Russia.; Russian National Medical Research University named after N.I. Pirogov, Russian Federation Ministry of Health. Department of Hematology, Oncology and Radiation Therapy, Moscow, Russia., Pankrashkina MM; The City Clinical Hospital named after S.P. Botkin Moscow Department of Health, Moscow, Russia.; National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Russian Federation Ministry of Health, Moscow, Russia.; Healthcare and Medical Management Research Institute of the Moscow City Health Department, Moscow, Russia., Chernikov MV; The City Clinical Hospital named after S.P. Botkin Moscow Department of Health, Moscow, Russia.; Healthcare and Medical Management Research Institute of the Moscow City Health Department, Moscow, Russia., Arshanskaya EG; The City Clinical Hospital named after S.P. Botkin Moscow Department of Health, Moscow, Russia.; National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Russian Federation Ministry of Health, Moscow, Russia., Tkachenko NE; National Medical Research Center of Children's Hematology, Oncology and Immunology named after Dmitry Rogachev of the Russian Federation Ministry of Health, Moscow, Russia.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 70-76.